Company / Shareholders' Equity
IDEAYA Biosciences, Inc. Shareholders' Equity History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.0B
FY2025
5-year range
$100.4M / $1.1B
FY2021-FY2025
Trend
-3.4%
vs FY2024
Sector context
#46 of 213
Health Care
What the data says
IDEAYA Biosciences, Inc.'s shareholders' equity of $1.0B is higher than 78% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 9 years, ranging from -$49M in FY2020 to $1.1B in FY2024.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 3-year CAGR of +72.8%. Top quartile in the Health Care sector.
Improved from $621M to $1.0B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +72.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-59.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +72.8%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 3.4% year-over-year.
- Ranks #46 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | -3.4% |
| FY2024 | $1.1B | +70.5% |
| FY2023 | $621.1M | +213.2% |
| FY2022 | $198.3M | +97.5% |
| FY2021 | $100.4M | +305.1% |
| FY2020 | -$48.9M | -148.8% |
| FY2019 | $100.4M | +305.1% |
| FY2018 | -$48.9M | -211.0% |
| FY2017 | -$15.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026